Biocryst Pharmaceuticals (BCRX.MX) Q2 2024 Earnings

6MayConfirmed
Q4 2023
Q2 2024
-5.3
-4.49
-3.68
-2.87

Details

Expected EPS
-3.5313198668999997
Actual EPS
-2.867577
Surprise EPS
0.66
Surprise Percent
+18.8%

Description

Biocryst Pharmaceuticals (BCRX.MX) has reported earnings of -2.867577 per share for Q2 2024.

0 Comments

Share your thoughts